In vivo and ex vivo study of metabolic and cellular effects of 5- fluorouracil chemotherapy in a mouse mammary carcinoma

Magnetic Resonance Imaging

Volumn 15, Issue 5, 1997, Pages 587-596

  Street, James C ^a   Alfieri, Alan A ^b   Traganos, Frank ^c   Koutcher, Jason A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

5 fluorouracil; NMR; Phosphocholine; Phosphodiester; Phosphomonoester; Tumor

Indexed keywords

CHOLINE; ETHANOLAMINE; FLUOROURACIL; GLYCEROPHOSPHOETHANOLAMINE; GLYCEROPHOSPHORYLCHOLINE; PHOSPHOETHANOLAMINE; PHOSPHORYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CELL CYCLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE METABOLISM;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; ETHANOLAMINES; FLUOROURACIL; MAGNETIC RESONANCE SPECTROSCOPY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; PHOSPHORYLCHOLINE; TISSUE EXTRACTS;

ANIMALIA;

EID: 0030852831     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(97)00013-1     Document Type: Article

References (45)

1. 1. Steen, R.G. Response of solid tumors to chemotherapy monitored by in vivo 31P nuclear magnetic resonance spectroscopy: a review. Cancer Res. 49:4075-4085; 1989.
2. 31P MRS of experimental tumours. NMR Biomed. 6:345-365; 1993.
3. 31P-nuclear magnetic resonance spectroscopic investigation of human neuroblastoma in situ. New Engl. J. Med. 312:1500-1505; 1985.
4. 4. Ruiz-Cabello, J.; Cohen, J.S. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 5:226-233; 1992.
5. 5. Negendank, W. Studies of human tumors by MRS: a review. NMR Biomed. 5:303-324; 1992.
6. 31P NMR analyses of phosphocholine metabolism in rat glioma cells. Magn. Reson. Med. 32:310-318; 1994.
7. 7. Freyer, J.P.; Schor, P.L.; Jarrett, K.A.; Neeman, M.; Sillerud, L.O. Cellular energetics measured by phosphorus nuclear magnetic resonance spectroscopy are not correlated with chronic nutrient deficiency in multicellular tumor spheroids. Cancer Res. 51:3831-3837; 1991.
8. 8. Ronen, S.M.; Stier, A.; Degani, H. NMR studies of the lipid metabolism of T47D human breast cancer spheroids. FEBS Lett. 266:147-149; 1990.
9. 31P NMR spectroscopy. J. Biol. Chem. 262:14875-14878; 1987.
10. 10. Warden, C.H.; Friedkin, M. Regulation of choline kinase activity and phosphatidylcholine biosynthesis by mitogenic growth factors in 3T3 fibroblasts. J. Biol. Chem. 260:6006-6011; 1985.
11. 11. Smith, T.A.D.; Eccles, S.; Ormerod, M.G.; Tombs, A.J.; Titley, J.C.; Leach, M.O. The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate. Br. J. Cancer 64:821-826; 1991.
12. 31P NMR spectral changes in a hypoxic tumor: possible association with in situ reoxygenation. In: Book of abstracts: Ninth Annual Meeting of the Society of Magnetic Resonance in Medicine. Berkeley, CA: SMRM; 1990: p. 1261.
13. 13. Koutcher, J.A.; Alfieri, A.A.; Devitt, M.L.; Rhee, J.G.; Kornblith, A.B.; Mahmood, U.; Merchant, T.E.; Cowburn, D. Quantitative changes in tumor metabolism. partial pressure of oxygen status post radiation. Cancer Res. 52:4620-4627; 1992.
14. 31P nuclear magnetic resonance spectroscopy. Cancer Res. 54:4885-4891; 1994.
15. 31P NMR spectroscopy. NMR Biomed. 8:149-158; 1995.
16. 31P NMR of Pentose Phosphate Pathway Block Secondary to Biochemical Modulation. NMR Biomed. in press; 1996.
17. 31P NMR and Tumor Growth Delay Studies. Magn. Reson. Med. in press; 1996.
18. 18. Stone, H.B.; Sinesi, M.S. Testing of new hypoxic cell sensitizers in vivo. Radiat. Res. 91:186-198; 1982.
19. 19. Alfieri, A.A.; Hahn, E.W. An in situ method for estimating cell survival in a solid tumor. Cancer Res. 38:3006-3011; 1978.
20. 20. Kim, J.H.; Alfieri, A.A.; Kim, S.H.; Young, C.W. Potentiation of radiation effects on two murine tumors by lonidamine. Cancer Res. 46:1120-1123; 1986.
21. 31P nuclear magnetic resonance with tumor growth in radioresistant and radiosensitive tumors. Radiat. Res. 121:312-319; 1990.
22. 22. Koutcher, J.A.; Barnett, D.; Kornblith, A.B.; Cowburn, D.; Brady, T.J.; Gerweck, L.F. Relationship of changes in pH and energy status to hypoxic cell fraction and hyperthermia sensitivity. Int. J. Radiat. Oncol. Biol. Phys. 18:1429-1435; 1990.
23. 31P nuclear magnetic spectroscopy. Cancer Res. 50:7252-7256; 1990.
24. 31P NMR for non-invasive evaluation of tumor metabolic status. Int. J. Radiat. Oncol. Biol. Phys. 12:793-799; 1986.
25. 25. Ballon, D.; Mahmood, U.; Jakubowski, A.; Koutcher, J.A. Resolution enhanced NMR spectroscopy in biological systems via magnetic susceptibility matched sample immersion chambers. Magn. Reson. Med. 30:754-758; 1993.
26. 26. Murukami, T.; Li, X.; Gong, J.; Bhatia, U.; Traganos, F.; Darzynkiewicz, Z. Induction of apoptosis by 5-azacytidine: drug concentration dependent differences in cell cycle specificity. Cancer Res. 55:3093-3098; 1995.
27. 31P nuclear magnetic resonance measurements of metabolic changes post radiation. Cancer Res. 55:1248-1254; 1995.
28. 31P resonances of phosphoethanolamine and phosphocreatine. NMR Biomed. 5:364-367; 1992.
29. 29. Bhuyan, B.K.; Scheidt, L.G.; Fraser, T.G. Cell cycle phase specificity of antitumor agents. Cancer Res. 32:398-407; 1972.
30. 30. Chen, T.-B.; Huzak, M.; Macura, S.; Vuk-Pavlovic, S. Somatostatin analogue octrotide modulates metabolism and effects of 5-fluorouracil and 5-fluorouridine in human colon cancer spheroids. Cancer Lett. 86:41-51; 1994.
31. 31. Maybaum, J.; Ullman, B.; Mandel, G.; Day, J.L.; Sadee, W. Regulation of RNA- and DNA-directed actions of 5-fluoropyrimidines in mouse T-lymphoma (S-49) cells. Cancer Res. 40:4209-4215; 1980.
32. 32. Li, S.-J.; Wehrle, J.P.; Glickson, J.D.; Kumar, N.; Braunschweiger, P.G. Tumor bioenergetics and blood flow in RIF-1 murine tumors treated with 5-fluorouracil. Magn. Reson. Med. 22:47-56; 1991.
33. 33. Sijens, P.E.; Baldwin, N.J.; Ng, T.C. Multinuclear MR investigation of the metabolic response of the murine RIF-1 tumor to 5 fluorouracil chemotherapy. Magn. Reson. Med. 19:373-385; 1991.
34. 34. Tozer, G.M.; Bhujwalla, Z.M.; Griffiths, J.R.; Maxwell, R.J. Phosphorus-31 magnetic resonance spectroscopy and blood perfusion of the RIF-1 tumor following X-irradiation. Int. J. Radiat. Oncol. Biol. Phys. 16:155-164; 1989.
35. 35. Braunschweiger, P.G. Effect of cyclophosphamide on the pathophysiology of RIF-1 solid tumors. Cancer Res. 48:4206-4210; 1988.
36. 36. Street, J.C.; Koutcher, J.A. Effect of radiotherapy and chemotherapy on composition of tumor membrane phospholipids. Lipids. In press: 1997.
37. 37. Shiao, Y.-J.; Vance, J.E. Evidence for an ethanolamine cycle: differential recycling of the ethanolamine moiety of phosphatidylethanolamine derived from phosphatidylserine and ethanolamine. Biochem. J. 310:673-679; 1995.
38. 38. Exton, J.H. Signalling through phosphatidylcholine breakdown. J. Biol. Chem. 265:1-4; 1991.
39. 39. Siddiqui, R.A.; Exton, J.H. Oleate stimulation of diacylglycerol formation from phosphatidylcholine through effects on phospholipase D and phosphatidate phosphohydrolase. Eur. J. Biochem. 210:601-607; 1992.
40. 40. Lamb, R.J.; Foster, K.; McGuffin, M.A. A distinction in vitro between rat liver phosphatidate phosphatase and phospholipase C. Biochim. Biophys. Acta 921:67-74; 1987.
41. 31P NMR measurements of the effects of unsaturated fatty acids on cellular phospholipid metabolism. Magn. Reson. Med. 35:481-488; 1996.
42. 2 - A mediator between proximal and distal effectors of inflammation. Immunol. Today 12:143-146; 1991.
43. 43. Pruzanski, W.; Vadas, P.; Browning, J. Secretory nonpancreatic group II phospholipase A(2) - role in physiologic and inflammatory process. J. Lipid Mediators 8:161-167; 1993.
44. 44. Chen, T.B.; Huzak, M.; Macura, S.; Vuk-Pavlovic, S. Somatostatin analogue of octreotide modulates metabolism and effects of 5-fluorouracil and 5-fluorouridine in human colon cancer spheroids. Cancer Lett. 86:41-51; 1994.
45. 45. Freyer, J.P. Phosphomonoesters and growth fraction in multicellular tumor spheroids. In: Proceedings of MR of Cancer: Physiology and Metabolism Workshop. Berkeley, CA: ISMRM; 1996:22-25.